Join
Live feed
·
INSIDERFilingvia Quantisnow
OKYO Pharma Limited logo

CHIEF DEVELOPMENT OFFICER Jacob Gary S was granted 3,500 shares, increasing direct ownership by 3% to 112,420 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
OKYO· OKYO Pharma Limited
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OKYO (OKYO Pharma Limited) and more on Quantisnow.